Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Benefits Of Grapefruit

FDA Approves Expanded Use Of Lilly's FORTEO(R) [teriparatide (rDNA Origin) Injection] To Treat Glucocorticoid-Induced Osteoporosis
Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved a new use for its osteoporosis drug FORTEO((R)) [teriparatide (rDNA origin) injection] to treat osteoporosis associated with sustained, systemic glucocorticoid therapy in men and women at high risk of fracture. Glucocorticoid therapy is the most common cause of secondary osteoporosis, leading to bone loss and an increased risk for fracture.(1)
generic viagra online
Breakthrough In The Quantum Control Of Light Could Impact Drug Design
Researchers at UC Santa Barbara have recently demonstrated a breakthrough in the quantum control of photons, the energy quanta of light. This is a significant result in quantum computation, and could eventually have implications in banking, drug design, and other applications.
News of the day
Office Of Tobacco Control Welcomes Removal Of All Tobacco Advertising From Retail Premises, Ireland
The Office of Tobacco Control (OTC) today (July 1, 2009) welcomed the commencement by the Department of Health and Children of further provisions of the Public Health (Tobacco) Acts, 2002 and 2004. The key provisions now commenced are:
Medical Devices

Hypoglycemia Increases Mortality Risk, Lengthens Hospital Stay For Diabetes Patients -- Even Outside The ICU

Diabetes patients who are hospitalized for non-critical illnesses, and develop hypoglycemia while hospitalized, are likely to remain hospitalized longer and face greater risk of mortality both during and after hospitalization, according to a study published in the July issue of Diabetes Care. This retrospective cohort study of more than 4,300 admissions, by researchers at Boston"s Brigham and Women"s Hospital, was the first to examine mortality risks for hospitalized diabetes patients outside a critical care setting. Previous research found an association between hypoglycemia in ICU patients and an increased risk of morality, seizures and coma. However, the majority of hospitalized diabetes patients are treated on the general ward. This study found that each hospital day in which a person with diabetes had at least one episode of hypoglycemia was associated with an 85.3 percent increased risk of dying as an inpatient and a 65.8 percent increased risk of dying within one year of discharge. The odds of inpatient death also tripled for every 10 mg/dl decrease in the lowest blood glucose during hospitalization. And, a patient"s length of stay increased by 2.5 days for each day spent in the hospital with a hypoglycemia episode. As a result of these findings, the researchers recommend carefully monitoring people with diabetes admitted to the general ward of the hospital for hypoglycemia and suggest interpreting its appearance as "a warning sign of impending clinical deterioration." "It could serve as a useful indicator for the necessity of increased monitoring, more aggressive treatment of infections, transitioning to a more intensive care setting, and case management," the study concludes. Diabetes Care, published by the American Diabetes Association, is the leading peer-reviewed journal of clinical research into one of the nation"s leading causes of death by disease. Diabetes also is a leading cause of heart disease and stroke, as well as the leading cause of adult blindness, kidney failure, and non-traumatic amputations. The American Diabetes Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009